Incidence and clinical significance of CDKN2/MTS1/P16(ink4a) and MTS2/P15(ink4b) gene deletions in childhood acute lymphoblastic leukemia

Pediatric Hematology and Oncology

Volumn 14, Issue 2, 1997, Pages 141-150

  Zhou, Muxiang ^a   Gu, Lubing ^a   Yeager, Andrew M ^a   Findley, Harry W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

p16 p15gene deletion; pediatric acute lymphoblastic leukemia

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; CYTOGENETICS; FEMALE; GENE DELETION; HUMAN; HUMAN CELL; INFANT; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; TUMOR SUPPRESSOR GENE;

EID: 0030941174     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019709030900     Document Type: Article

References (39)

1. Marshall C. Tumor suppressor genes. Cell. 1991;64:313-326.
2. Stanbridge E. Functional evidence for human tumor suppressor genes: chromosome and molecular genetic studies. Cancer Surv. 1992;12:5.
3. Prokocimer M, Rotter V. Structure and function of p53 in normal cells and their aberrations in cancer cells: projection on the hematologic cell lineages. Blood. 1994;84:2391-2411.
4. Hsiao M, Yu A, Yeargin J, Ku D, Haas M. Nonhereditary p53 mutations in T-cell acute lymphoblastic leukemia associated with the relapse phase. Blood. 1994;83:2922-2930.
5. Diccianni MB, Yu J, Hsiao M, Mukherjee S, Shao LE, Yu AL. Clinical significance of p53 mutations in relapsed T-cell acute lymphoblastic leukemia. Blood. 1994;84:3105-3122.
6. Wada M, Bartram C, Nakamura H, et al. Analysis of p53 mutations in large series of lymphoid hematological malignancies of childhood. Blood. 1993;82:3163-3169.
7. Kowalczyk J, Sandberg AA. A possible subgroup of ALL with 9p-: short communication. Cancer Genet Cytogenet. 1983;9:383.
8. Chilcote RR, Brown E, Rowley JD. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N Engl J Med. 1985;313:286-291.
9. Murphy SB, Raimondi SC, Rivera GK, et al. Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia: association with high-risk clinical features. Blood. 1989;74: 409-415.
10. Kamb A, Gruis NA, Weaver-Feldhaus J, et al. A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994;264:436-440.
11. Weaver-Feldhaus J, Gruis N, Neuhausen S, et al. Localization of a putative tumor suppressor gene by using homozygous deletions in melanomas. Proc Natl Acad Sci USA. 1994;91:7563-7567.
12. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993;366:704-707.
13. Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994;368:753-756.
14. Ogawa S, Hirano N, Sato N, et al. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (p16) gene in human leukemia. Blood. 1994;84:2431-2435.
15. INK4B) display frequent homozygous deletion in primary cells from T- but not from B-cell lineage acute lymphoblastic leukemia. Blood. 1994;84:4038-4044.
16. Quesnel B, Preudhomme C, Philippe N, et al. P16 gene homozygous deletion in acute lymphoblastic leukemia. Blood. 1995;85:657-663.
17. ink4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature. 1994;371:257-261.
18. ink4) gene in cell lines established from children with acute lymphoblastic leukemia. Leukemia. 1995;9:1159-1161.
19. Jagasia AA, Sher DA, Le Moine P, et al. Deletion or lack of expression of CDKN2 (CDK4I/MTS1/ INK4A) and MTS2 (INK4B) in acute lymphoblastic leukemia cell lines reflects the phenotype of the uncultured primary leukemia cells. Leukemia. 1996;10:624-628.
20. Cairns P, Mao L, Merlo A, et al. Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science. 1994;65:415-417.
21. Spruck C, Gonzalez-Zuleta M, Shibata A, et al. p16 gene in uncultured tumours. Nature. 1994;370: 183-184.
22. Bennet J, Catovsky D, Daniel M, et al. Proposals for the classification of the acute leukemias. Br J Haematol. 1967;33:451-458.
23. Shuster J, Falletta J, Pullen D, et al. Prognostic factors in childhood T-cell acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1990;75:166-173.
24. Sullivan M, Pullen J, Crist W, et al. Clinical and biological heterogeneity of childhood B-cell leukemia: implications for clinical trials. Leukemia. 1990;4:6-11.
25. Abshire TC, Buchanan G, Jackson J, et al. Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study. Leukemia. 1992;6:357-362.
26. Zhou M, Yeager AM, Smith SD, Findley HW. Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood. 1995;85:1608-1614.
27. He J, Allen JR, Collins VP, Day RS, James CD. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletions in glioma cell lines. Cancer Res. 1994;54:5804-5807.
28. Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. J Am Stat Assoc. 1958; 53:547-481.
29. Lehmann EL. Nonparametrics, Statistical Methods Based on Ranks. San Francisco: Holden-Day; 1975: 204.
30. Hunter T, Pines J. Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age. Cell 1994;79: 573-583.
31. Hirama T, Koeffler HP. Role of cyclin-dependent kinase inhibitors in the development of cancer. Blood. 1995;86:841-854.
32. Rassool O, Heyman M, Brandter L, et al. p15 and p16 gene inactivation in acute lymphoblastic leukemia. Blood. 1995;85:3431-3436.
33. Takeuchi S, Bartram C, Seriu T, et al. Analysis of a family of cyclin dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia. Blood 1995; 86:755-760.
34. Guidal-Giroux C, Gerard B, Cave H, et al. Deletion mapping indicates that MTS1 is the target of frequent deletions at chromosome 9p21 in pediatric acute lymphoblastic leukemia. Br J Haematol. 1996;92:410-419.
35. Delmer A, Tang R, Senamaud-Beaufort C, Paterlini P, Brechot C, Zittoun R. Alterations of cyclin-dependent kinase 4 inhibitor gene structure and expression in acute lymphoblastic leukemias. Leukemia. 1995;9:1240-1245.
36. Sill H, Aguiar C, Schmidt H, Hochhaus A, Goldman J, Cross N. Mutational analysis of the p15 and p16 genes in acute leukemias. Br J Haematol 1996;92:681-683.
37. Duro D, Bernard O, Della Valle V, Berger R, Larsen CJ. A new type of p16/MTS1 gene transcript expressed in B-cell malignancies. Oncogene. 1995;11:21-29.
38. ink4A transcript. Cancer Res. 1995;55:2995-2997.
39. Stone S, Jiang P, Dayananth P, et al. Complex structure and regulation of p16 (MTS1) locus. Cancer Res. 1995;55:2988-2994.